PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Carl Zeiss Meditec AG (AFX.DE)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINDE0005313704
SectorHealthcare
IndustryMedical Instruments & Supplies

Highlights

Market Cap€5.99B
EPS (TTM)€2.28
PE Ratio29.36
PEG Ratio2.92
Total Revenue (TTM)€1.96B
Gross Profit (TTM)€1.27B
EBITDA (TTM)€191.38M
Year Range€54.60 - €122.59
Target Price€154.33

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons: AFX.DE vs. ASML

Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Carl Zeiss Meditec AG, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


200.00%250.00%300.00%350.00%400.00%MayJuneJulyAugustSeptemberOctober
245.52%
235.57%
AFX.DE (Carl Zeiss Meditec AG)
Benchmark (^GSPC)

Returns By Period

Carl Zeiss Meditec AG had a return of -29.48% year-to-date (YTD) and -12.32% in the last 12 months. Over the past 10 years, Carl Zeiss Meditec AG had an annualized return of 13.33%, outperforming the S&P 500 benchmark which had an annualized return of 11.53%.


PeriodReturnBenchmark
Year-To-Date-29.48%20.57%
1 month13.76%4.18%
6 months-35.10%10.51%
1 year-12.32%35.06%
5 years (annualized)-7.72%14.29%
10 years (annualized)13.33%11.53%

Monthly Returns

The table below presents the monthly returns of AFX.DE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-0.28%15.41%2.77%-14.42%-14.58%-22.45%-3.50%4.74%7.23%-29.48%
202311.92%-4.28%2.19%-4.84%-13.92%-5.54%6.37%-12.94%-9.70%-1.30%0.71%20.07%-15.46%
2022-23.42%-0.49%4.96%-18.07%3.20%-8.33%24.76%-12.60%-13.49%14.05%5.39%-8.71%-35.83%
202118.46%-3.64%3.38%14.05%3.86%7.42%15.25%-0.37%-11.25%4.76%1.72%4.46%70.32%
2020-2.81%-14.25%-5.99%1.81%2.39%-5.75%2.13%7.25%14.41%2.69%0.81%-2.59%-2.74%
201915.89%-5.24%-0.04%17.60%-3.77%2.97%14.64%5.48%-0.29%-6.55%13.55%2.43%67.64%
20181.91%-3.70%2.07%9.74%5.06%-1.18%13.69%14.82%-4.98%-0.07%-15.80%11.97%33.36%
2017-1.27%18.19%-2.11%4.35%11.39%-1.31%-0.31%-7.51%5.41%3.61%8.61%4.14%49.25%
2016-4.64%6.34%-6.25%6.36%21.99%4.85%-8.33%-2.35%4.34%-3.75%-1.39%8.36%24.23%
201510.69%5.18%0.73%-6.82%-2.12%2.99%12.05%-7.41%5.35%6.62%1.03%6.04%37.53%
2014-10.24%1.98%-6.08%7.58%-0.05%2.21%-0.89%4.50%-0.86%-6.63%2.96%-4.57%-10.99%
201310.62%-0.25%4.49%-5.72%5.98%3.47%-0.02%-9.57%-4.27%5.53%2.38%1.55%13.19%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AFX.DE is 26, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of AFX.DE is 2626
AFX.DE (Carl Zeiss Meditec AG)
The Sharpe Ratio Rank of AFX.DE is 2424Sharpe Ratio Rank
The Sortino Ratio Rank of AFX.DE is 2222Sortino Ratio Rank
The Omega Ratio Rank of AFX.DE is 2222Omega Ratio Rank
The Calmar Ratio Rank of AFX.DE is 2929Calmar Ratio Rank
The Martin Ratio Rank of AFX.DE is 3232Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Carl Zeiss Meditec AG (AFX.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


AFX.DE
Sharpe ratio
The chart of Sharpe ratio for AFX.DE, currently valued at -0.34, compared to the broader market-4.00-2.000.002.00-0.34
Sortino ratio
The chart of Sortino ratio for AFX.DE, currently valued at -0.21, compared to the broader market-4.00-2.000.002.004.00-0.21
Omega ratio
The chart of Omega ratio for AFX.DE, currently valued at 0.97, compared to the broader market0.501.001.500.97
Calmar ratio
The chart of Calmar ratio for AFX.DE, currently valued at -0.20, compared to the broader market0.002.004.006.00-0.20
Martin ratio
The chart of Martin ratio for AFX.DE, currently valued at -0.49, compared to the broader market-10.000.0010.0020.0030.00-0.49
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.79, compared to the broader market-4.00-2.000.002.002.80
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.73, compared to the broader market-4.00-2.000.002.004.003.73
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.51, compared to the broader market0.501.001.501.51
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.46, compared to the broader market0.002.004.006.002.46
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 17.01, compared to the broader market-10.000.0010.0020.0030.0017.01

Sharpe Ratio

The current Carl Zeiss Meditec AG Sharpe ratio is -0.34. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Carl Zeiss Meditec AG with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00MayJuneJulyAugustSeptemberOctober
-0.34
2.37
AFX.DE (Carl Zeiss Meditec AG)
Benchmark (^GSPC)

Dividends

Dividend History

Carl Zeiss Meditec AG granted a 1.59% dividend yield in the last twelve months. The annual payout for that period amounted to €1.10 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend€1.10€1.10€0.90€0.50€1.30€0.55€0.55€0.42€0.38€0.40€0.45€0.40

Dividend yield

1.59%1.11%0.76%0.27%1.19%0.48%0.81%0.81%1.09%1.40%2.13%1.65%

Monthly Dividends

The table displays the monthly dividend distributions for Carl Zeiss Meditec AG. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024€0.00€0.00€1.10€0.00€0.00€0.00€0.00€0.00€0.00€0.00€1.10
2023€0.00€0.00€1.10€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€1.10
2022€0.00€0.00€0.90€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.90
2021€0.00€0.00€0.00€0.00€0.50€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.50
2020€0.00€0.00€0.65€0.00€0.00€0.00€0.00€0.65€0.00€0.00€0.00€0.00€1.30
2019€0.00€0.00€0.55€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.55
2018€0.00€0.00€0.00€0.55€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.55
2017€0.00€0.00€0.00€0.00€0.42€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.42
2016€0.00€0.00€0.00€0.38€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.38
2015€0.00€0.00€0.40€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.40
2014€0.00€0.00€0.45€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.45
2013€0.40€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.40

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%1.6%
Carl Zeiss Meditec AG has a dividend yield of 1.59%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%79.7%
Carl Zeiss Meditec AG has a payout ratio of 79.71%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%MayJuneJulyAugustSeptemberOctober
-64.47%
0
AFX.DE (Carl Zeiss Meditec AG)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Carl Zeiss Meditec AG. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Carl Zeiss Meditec AG was 91.83%, occurring on Sep 6, 2001. Recovery took 3725 trading sessions.

The current Carl Zeiss Meditec AG drawdown is 64.47%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.83%Mar 27, 2000366Sep 6, 20013725May 9, 20164091
-71.32%Sep 22, 2021763Sep 12, 2024
-42.59%Jan 21, 202042Mar 18, 2020144Oct 12, 2020186
-20.37%Aug 30, 201866Nov 30, 201831Jan 21, 201997
-16.98%Jul 14, 201694Nov 23, 201657Feb 13, 2017151

Volatility

Volatility Chart

The current Carl Zeiss Meditec AG volatility is 15.78%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%MayJuneJulyAugustSeptemberOctober
15.78%
3.32%
AFX.DE (Carl Zeiss Meditec AG)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Carl Zeiss Meditec AG over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Carl Zeiss Meditec AG compared to its peers in the Medical Instruments & Supplies industry.


PE Ratio
100.0200.0300.0400.029.4

The chart displays the price to earnings (P/E) ratio for AFX.DE in comparison to other companies of the Medical Instruments & Supplies industry. Currently, AFX.DE has a PE value of 29.4. This PE ratio falls in the average range for the industry.

PEG Ratio
0.05.010.015.020.02.9

The chart displays the price to earnings to growth (PEG) ratio for AFX.DE in comparison to other companies of the Medical Instruments & Supplies industry. Currently, AFX.DE has a PEG value of 2.9. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Carl Zeiss Meditec AG.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items